Find research datasets worth reusing

opennotspecifiedJun 2021View details →

Fig. 1 in Carotenoid profiles of red- and yellow-colored arils of cultivars of Taxus baccata L. and Taxus × media Rehder

Fig. 1. HPLC-DAD chromatograms of carotenoids from (a) red arils of Taxus × media Rehder 'Hicksii' and (b) yellow arils of Taxus baccata L. 'Lutea' at 504 (450) and 475 nm, respectively. See Tables 2 and 3 for compound assignment. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)

Fig. 4 in Biochemical and molecular insights of PGPR application for the augmentation of carotenoids, tocopherols, and folate in the foliage of Moringa oleifera

Fig. 4. HPLC Chromatograms of 1–5,6,7,8 tetrahydro folic acid (THF) in Control and 937b- B. subtilis IN937b treated M. oleifera foliage.

Fig. 3 in Biochemical and molecular insights of PGPR application for the augmentation of carotenoids, tocopherols, and folate in the foliage of Moringa oleifera

Fig. 3. HPLC Chromatograms of 1- Violaxanthin, 2- Lutein, 3- Chl b, 4-Chl a, 5- β-carotene in control and GBO3- B. subtilis GB03 treated M. oleifera foliage.

Fig. 5 in Biochemical and molecular insights of PGPR application for the augmentation of carotenoids, tocopherols, and folate in the foliage of Moringa oleifera

Fig. 5. Differential expression of mRNA levels of γ-tocopherol methyltransferase (γ-TMT), phytoene synthase (PSY), phytoene desaturase (PDS), lycopene β-cyclase (LBC) and dihydrofolate reductase thymidylate (DHFR-TS) in M. oleifera foliage after treatment with GB03-B. subtilis GB03, T4-B. pumilus T4, COM1- Combination 1, COM2- Combination 2, COM3-Combination 3. Experiments were repeated three times, each with three replicates. Columns without a common lowercase letter indicate significantly different values among treatments based on Tukey's test (P value ≤ 0.05).

Fig. 2 in Biochemical and molecular insights of PGPR application for the augmentation of carotenoids, tocopherols, and folate in the foliage of Moringa oleifera

Fig. 2. HPLC Chromatograms of 1- δ-tocopherol, 2- γ-tocopherol and 3- α-tocopherol in control, 937a- B. amyloliquefaciens IN937a and SE34- B. pumilus SE34 treated M. oleifera foliage.

Fig. 1. M. oleifera treated with 1 in Biochemical and molecular insights of PGPR application for the augmentation of carotenoids, tocopherols, and folate in the foliage of Moringa oleifera

Fig. 1. M. oleifera treated with 1) B. amyloliquefaciens IN937a, 2) B. subtilis IN937b, 3) Brevibacillus brevis IPC 11, 4) B. subtilis GB03, 5) B. pumilus INR7, 6) B. pumilus SE34, 7) B. pumilus T4, 8) P. fluorescens UOM14 shown compared to control.

Fig. 6 in In silico characterization of the impact of mutation (LEU112PRO) on the structure and function of carotenoid cleavage dioxygenase 8 in Oryza sativa

Fig. 6. Projections of FEL of CCD8 transporter A) Wild-type, (B) Mutant, (C) Complex I (wild-type & auxin complex), (D) Complex II (wild-type & cytokinin complex), (E) Complex III (mutant-auxin complex) and (F) Complex IV (Mutant-cytokinin complex) throughout 100 ns simulation. Several colours in panel suggests motion range. White: highest energy configuration; Dark black: lowest energy configuration. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)

Fig. 7 in In silico characterization of the impact of mutation (LEU112PRO) on the structure and function of carotenoid cleavage dioxygenase 8 in Oryza sativa

Fig. 7. "Three-dimensional" representation of intermolecular interaction in (A) Complex I, (B) Complex II, (C) Complex III and (B) Complex IV after 100 ns simulation. Green, cyan and red color represent wildtype CCD8 protein, mutant CCD8 protein and auxin/ cytokinin, respectively. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)

Fig. 3 in In silico characterization of the impact of mutation (LEU112PRO) on the structure and function of carotenoid cleavage dioxygenase 8 in Oryza sativa

Fig. 3. The "Z-score" plot of modelled CCD8 protein produced from the "ProSA-web" server. (A) Wild-type (Before simulation), (B) Wild-type (After 100 ns simulation) and (C) Mutant (After 100 ns simulation).

Fig. 4. The stability parameters for modelled D10 in In silico characterization of the impact of mutation (LEU112PRO) on the structure and function of carotenoid cleavage dioxygenase 8 in Oryza sativa

Fig. 4. The stability parameters for modelled D10 protein: wild-type (Blue), mutant (Green), Complex I (wild-type & auxin complex) (orange), Complex II (wild-type & cytokinin complex) (purple), Complex III (mutant-auxin complex) (red) and (D) Complex IV (mutant-cytokinin complex) (black) throughout 100 ns simulation: (A) RMSD, (B) RMSF, (C) PCA of C-α movement, and (D) Radius of gyration. The trajectory projected to the two-dimensional space. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)

Fig. 2 in In silico characterization of the impact of mutation (LEU112PRO) on the structure and function of carotenoid cleavage dioxygenase 8 in Oryza sativa

Fig. 2. "Ramachandran plot" of three-dimensional CCD8 protein produced through "PROCHECK". (A) Wild-type (Before simulation), (B) Wild-type (After 100 ns simulation) and (C) Mutant (After 100 ns simulation).

Fig. 1 in In silico characterization of the impact of mutation (LEU112PRO) on the structure and function of carotenoid cleavage dioxygenase 8 in Oryza sativa

Fig. 1. "Three-dimensional" structure of CCD8 protein. (A) "Super-impose" structure of Wild-type CCD8 protein (green) and chain A of 4RSE (Red) (A) Wild-type is made up of 10 α-helix and 25 β-strands. (B) Mutant is made up of 11 α-helix and 24 β- strands. Light grey: loop; red: α-helix and cyan: β- strands. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)

restrictedIPD-UNDECIDEDFeb 2026View details →

Bioavailability of Yellow Maize Carotenoids in Humans

ClinicalTrials.gov study NCT00636038. IPD Sharing: Not stated. Countries: 1. Publications: 1.

Prospective Study of Adjunctive Carotenoids Plus Anti-oxidants in Anti-VEGF Treated Diabetic Macular Edema

ClinicalTrials.gov study NCT03866005. IPD Sharing: NO. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →

The Effects of a Carotenoid Intervention on Cognitive Function

ClinicalTrials.gov study NCT02023645. IPD Sharing: Not stated. Countries: 1. Publications: 1.

Carotenoid Response to the Intake of Vegetables and Fruits

ClinicalTrials.gov study NCT01403844. IPD Sharing: NO. Countries: 1. Publications: 1.

Diabetic Retinopathy Functional Evaluation Study: Monitoring Carotenoid Vitamins Treatment Using ERG

ClinicalTrials.gov study NCT04117022. IPD Sharing: NO. Countries: 1. Publications: 1.

Enhancing Children's Cognitive Function and Achievement Through Carotenoid Consumption

ClinicalTrials.gov study NCT05177679. IPD Sharing: NO. Countries: 1. Publications: 1.

Probiotics for Enhanced Tissue Carotenoid Status in Premenopausal Women

ClinicalTrials.gov study NCT04511052. IPD Sharing: NO. Countries: 1. Publications: 0.